Tolvaptan

Spécifications

150683-30-0Numéro CAS

691-537-5Numéro CE

N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamideNom IUPAC

C26H25ClN2O3Formule chimique

448.9 g/molMasse molaire

Tolvaptan; 150683-30-0; OPC-41061; jinarc; DTXSID3048780; JYNARQUE; CHEBI:32246; 21G72T1950; DTXCID9028706; 7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine; Benzamide, N-(4-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-3-methylphenyl)-2-methyl-; tolvaptanum; Benzamide, N-[4-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methyl-; N-(4-(7-chloro-5-hydroxy2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide; N-[4-(7-chloro-5-hydroxy2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide; RefChem:56517; C03XA01; OPC41061; N-(4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide; OPC 41061; N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide; (R)-(+)-Tolvaptan; MFCD09838782; CHEMBL344159; C26H25ClN2O3; N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide; NCGC00183001-01; N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide; (S)-(-)-Tolvaptan; UNII-21G72T1950; benzazepine derivative, 32; Tolvaptan [USAN:INN:BAN]; Tolvaptan?; HSDB 8196; Tolvaptan [INN]; N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methyl-benzamide; 1H-1-Benzazepine, benzamide deriv.; 1-[4-(2-Methylbenzoylamino)-2-methylbenzoyl]-7-chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-ol; OPC 41061; Samsca; Tolvaptan; Tolvaptan (Standard); TOLVAPTAN [JAN]; TOLVAPTAN [MI]; TOLVAPTAN [USAN]; TOLVAPTAN [VANDF]; TOLVAPTAN [MART.]; TOLVAPTAN [WHO-DD]; Epitope ID:1635951; TOLVAPTAN [EMA EPAR]; Tolvaptan (OPC-41061); SCHEMBL242421; Tolvaptan - Bio-X trade mark; GTPL2226; orb1305683; TOLVAPTAN [ORANGE BOOK]; SCHEMBL29389767; SCHEMBL29720852; SCHEMBL29776655; BDBM35723; OPC-41061(TOLVAPTAN); CHEBI:231425; GYHCTFXIZSNGJT-UHFFFAOYSA-N; HMS3604L08; HMS3656K20; HMS3744A09; HMS5081B09; MSK11103; Tox21_113256; EBC-07798; HY-17000R; PDSP1_001738; PDSP2_001721; s2593; AKOS015994735; Tolvaptan, >=98% (HPLC), powder; CCG-269223; CS-0572; FT34175; KS-1315; AC-22748; BT164486; HY-17000; N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide; N-[4-(9-chloro-6-hydroxy-2-azabicyclo[5.4.0]undeca-8,10,12-triene-2-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide; CAS-150683-30-0; SW219182-1; EN300-123019; AB01565822_02; F361970; L001628; Q426132; SR-01000942265; SR-01000942265-1; BRD-A82035391-001-02-7; Z1546610480; (+-)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl) carbonyl)-o-tolu-m-toluidide; (+-)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide; (+/-)-4'-((7-CHLORO-2,3,4,5-TETRAHYDRO-5-HYDROXY-1H-1-BENZAZEPIN-1-YL) CARBONYL)-O-TOLU-M-TOLUIDIDE; 1-[4-(2-methylbenzoylamino)-2-methylbenzoyl]-7-chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-ol; 5-hydroxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1h-benzazepine; 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methyl benzoyl amino) benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine; 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino) benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine; 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine; N-[4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-benzo[b]azepine-1-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide; N-{4-[(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl}-2-methylbenzamideSynonymes